Zongqi Xia MD PhD
Neuroimmunology/Multiple Sclerosis
Associate Professor of Neurology, Biomedical Informatics, Clinical and Translational Science, University of Pittsburgh
Join to View Full Profile
3501 Fifth AvenueBST3-7014Pittsburgh, PA 15260
Dr. Xia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Zongqi Xia is a board-certified neurologist with subspecialty expertise in clinical neuroimmunology and a physician scientist. He directs the Program in Translational and Computational Neuroimmunology at the University of Pittsburgh. His research lies at the intersection of clinical neuroimmunology and data science. His interdisciplinary research team leverages multi-modal patient-derived data and deploys quantitative science approaches to investigate the underlying disease mechanisms and translate these findings into the clinical arena to improve individualized risk prediction, prevention, and management in multiple sclerosis and other related disorders of neuroinflammation.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2006 - 2009
Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 2005 - 2006
Case Western Reserve University School of MedicineClass of 2005, MD, PhD
Certifications & Licensure
PA State Medical License 2015 - 2026
MA State Medical License 2009 - 2016
OH State Medical License 2005 - 2006
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
- Prebiotic vs Probiotic in Multiple Sclerosis Start of enrollment: 2020 Mar 11
Publications & Presentations
PubMed
- Circulating cell-free DNA methylation profiles as noninvasive multiple sclerosis biomarkers: A proof-of-concept study.Hailu Fu, Kevin Huang, Wen Zhu, Lili Zhang, Ravi Bandaru
Medrxiv. 2025-02-20 - Supervised machine learning compared to large language models for identifying functional seizures from medical records.Wesley T Kerr, Katherine N McFarlane, Gabriela Figueiredo Pucci, Danielle R Carns, Alex Israel
Epilepsia. 2025-02-17 - DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.John R Corboy, Robert J Fox, Gary Cutter, Eric Engebretson, Aaron Miller
Multiple Sclerosis. 2025-02-01
Journal Articles
- Common Variation near IRF6 Is Associated with IFN-Β-induced Liver Injury in Multiple SclerosisJoshua C Denny, Zongqi Xia, Naga Chalasani, Nature
Press Mentions
Study Finds That Some Family Members of People with MS Show Possible Early Signs of the Disease Without SymptomsJanuary 25th, 2017
Grant Support
- Leveraging electronic health records to optimize treatment selection and response in multiple sclerosisUNIVERSITY OF PITTSBURGH AT PITTSBURGH2016–2027
- Leveraging electronic health records to optimize treatment selection and response in multiple sclerosisUNIVERSITY OF PITTSBURGH AT PITTSBURGH2016–2027
- Real-world impact of the COVID-19 pandemic in people with multiple sclerosisUNIVERSITY OF PITTSBURGH AT PITTSBURGH2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
